Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

Case study with first patient images of half-life engineered MP0712 from compassionate care use show specific uptake in primary tumors and metastatic lesionsMP0712 Radio-DARPin leverages rapid ...

MASH resolution and weight loss, and strong evidence of anti-fibrotic activity with a favorable tolerability profile Significant improvements observed in secondary endpoints, including reductions in ...

Analysis of the data from the open-label pivotal trial of oxylanthanum carbonate (OLC) highlights that pill burden was ...

Let's be honest: crafting a compelling presentation from a blank slate is a universal pain point. It's time-consuming, ...

Privacy campaigners have criticised the European Commission's plans to overhaul the bloc's digital privacy and AI rules, ...

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced two ...

Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, ...

SYRACUSE, NY / ACCESS Newswire / November 11, 2025 / Repair Biotechnologies, Inc. ( today announced the recent presentation of preclinical data at American Heart Association's (AHA) Scientific ...

East Palo City Council on Tuesday postponed a five-year contract renewal of its Flock Automated License Plate Reader ...

Struggling with your slides? Here's how Gemini's latest updates can help you polish your presentation, and who can access them.

Lloyds Banking Group used information from the personal bank accounts of more than 30,000 staff as part of its pay ...